You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
Hepatitis C - Hematological Disorders / Neutropenia and Anemia
Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin 1-11-2011 Viramidine Fails to Show Non-inferiority to Ribavirin at Tested Doses, but Causes Less Anemia 1-19-2010 Open Phase 3 Study of Eltrombopag for Raising Platelet Levels in Patients with Chronic Liver Disease and Thrombocytopenia 2-27-2009 Prodrug Taribavirin Produces Equivalent Response, but Less Anemia than Ribavirin at 48 Weeks 2-27-2008 Study Demonstrates Safety of Erythropoiesis-stimulating Agents for Managing Ribavirin-related Anemia in Hepatitis C Patients 7-29-2008 Taribavirin Efficacy Similar to Ribavirin in Combination Therapy for Hepatitis C, but with Less Anemia 5-09-2008
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Chilren / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
